President Joe Biden has told Indo-Pacific allies that he believes China’s increasing military assertiveness is an effort to ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Coalition of civil society and patient voices red-flags proposal for Pathogen Access and Benefit Sharing, calling for ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

SEATTLE — Third Avenue in Seattle is slowly getting a facelift. The newest addition is overhead lights that were strung ...

Molecular Cancer Research publishes articles featuring novel, basic cancer research discoveries that prioritize broad molecular and cellular processes. Areas of emphasis include cell cycle and ...

Winners of the 2024 Lasker Awards include researchers who discovered and developed GLP-1 agonists, infectious disease ...

The phase 1 portion is intended to determine the safety and the optimal dose of Covigenix VAX-002 as a COVID-19 booster vaccine ... and advance safe and effective RNA or DNA vaccines and therapeutics.

As the World Health Organization (WHO) has declared mpox an emergency, the Clinical Trials Arena team investigates ongoing vaccine trials.

Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious ...